Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.
First Name *
Last Name *
Email Address (Verify) *
We will request your mailing address on the next page.
We will request your mailing address on the next page.

Corrections

JHOP - June 2021 Vol 11, No 3 - Original Article

In Volume 10, Number 4 (August 2020) of the journal, the article “Assessing the Impact of Limited Distribution Drug Networks Based on Time to Accessing Oral Oncolytic Agents at an Integrated Specialty Pharmacy,” by Wyatt et al, contained an error in Figure 2 on page 203. The limited-distribution drugs and the non–limited-distribution drugs graphs were labeled incorrectly, showing the wrong color for the 2 categories. The Figure has been corrected in the article online.

In Volume 11, Number 1 (February 2021) of the journal, the article “Olanzapine versus Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting Prophylaxis in Patients Receiving Single-Day High-Dose Melphalan,” by Ekinci et al, contained an error on page 38. The last part of the sentence ending with “the longstanding practice had been to use empirically the FOD regimen in such patients, and use dexamethasone only on day 1 post-HSCT,” should have read “the longstanding practice had been to use empirically the FOD regimen in such patients.” This error has been corrected in the article online.

Related Items
Impact of Using Adjusted Body Surface Area in Obese Patients Receiving Ablative Busulfan plus Fludarabine Conditioning Regimen Before Hematopoietic Stem-Cell Transplant
JHOP - December 2021 Vol 11, No 6 published on December 16, 2021 in Original Article
Evaluating Antibiotic Use and Opportunities for Intervention in Patients with Cancer
JHOP - December 2021 Vol 11, No 6 published on December 16, 2021 in Original Article
Outcomes of Pharmacist-Provided Telehealth Services in an Ambulatory Oncology Clinic During the COVID-19 Pandemic
Colleen Bohnenkamp, PharmD, BCOP, BCPS, Grace A. Martin, PharmD, BCOP, Laure DuBois, PharmD, BCOP, Olivia Fahey, PharmD, BCOP, Jade Hefler, PharmD
JHOP - October 2021 Vol 11, No 5 published on October 29, 2021 in Original Article
Tolerance of Oral Targeted Therapies in Patients with Metastatic Renal-Cell Carcinoma and Renal Impairment
Jessica McKernan, PharmD, BCOP, Laura Schmidt, PharmD, BCOP, Melissa Rhoades, PharmD, BCOP
JHOP - October 2021 Vol 11, No 5 published on October 29, 2021 in Original Article
Efficacy of an Enteral Urine Alkalinization Strategy During Intravenous Sodium Bicarbonate Shortage in Patients with Cancer Receiving High-Dose Methotrexate
Christopher Sinoimeri, PharmD, Matthew Lei, PharmD, BCOP, Stephanie Monaco, PharmD, BCOP, Uvette Lou, PharmD, BCOP
JHOP - October 2021 Vol 11, No 5 published on October 28, 2021 in Original Article
Safety of Inactivated Vaccines in Patients Receiving Immune Checkpoint Inhibitors
Austin Kurkowski, PharmD, BCOP, Grace A. Martin, PharmD, BCOP, Shelbie Ralph, PharmD, BCOP, Zahra Mahmoudjafari, PharmD, BCOP, Dennis Grauer, PhD, MS, Elizabeth Wulff-Burchfield, MD
JHOP - August 2021 Vol 11, No 4 published on August 17, 2021 in Original Article
Myeloablative and Reduced-Intensity Preparative Regimens for Allogeneic Transplant in the Outpatient versus Inpatient Setting in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
Gretchen Pardo, PharmD, Beth Eddy, PharmD, BCOP, Zahra Mahmoudjafari, PharmD, BCOP, Dennis Grauer, PhD, MS, Joseph McGuirk, DO
JHOP - August 2021 Vol 11, No 4 published on August 17, 2021 in Original Article
Comparing Cyclophosphamide-Based versus Etoposide-Based Chemomobilization for Autologous Hematopoietic-Cell Transplant in Patients with Lymphoma
Taylor Dennison, PharmD, Zachary Pedretti, PharmD, Jing Zhu, PharmD, Kurtis Stocker, PharmD, Ryan Shaw, PharmD, Tatjana Grgic, PharmD, Maurice Alexander, PharmD, Marcie Riches, MD, MS, Hillary Heiling, BS, Jonathan Ptachcinski, PharmD
JHOP - August 2021 Vol 11, No 4 published on August 17, 2021 in Original Article, Transplant, Lymphoma
Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis
Katherine P. Morgan, PharmD, BCOP, CPP, Yujiao Sun, PharmD, Allison Deal, Jared Weiss, MD, Amber Cipriani, PharmD, BCOP
JHOP - June 2021 Vol 11, No 3 published on June 16, 2021 in Original Article
Immune-Related Adverse Events Linked to Immune Checkpoint Inhibitors: Retrospective Analysis of a Single-Center Veteran Population
Jessica M. Tran, PharmD, BCPS, Ni-Chi Wu, PharmD, BCOP, BCPS, Rajkumar J. Sevak, PhD, RPh, Pankaj Gupta, MD, FACP
JHOP - June 2021 Vol 11, No 3 published on June 16, 2021 in Original Article
Copyright © Green Hill Healthcare Communications, LLC. All rights reserved.